Search filters

List of works by Jannik Langtved Pallisgaard

A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery

Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation

scientific article published on June 2017

Beta-blocker subtype and risks of perioperative adverse events following non-cardiac surgery: a nationwide cohort study

scientific article

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study

scientific article published on 29 October 2015

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation

scientific article published on 01 November 2020

Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism. A Danish nationwide registry-based study

scientific article published on 16 March 2017

Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study

scientific article

High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome

scientific article published on 04 February 2018

Management and prognosis of atrial fibrillation in the diabetic patient.

scientific article published on June 2015

NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study

scientific article

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

scientific article published on 11 August 2016

Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.

scientific article

Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation

scientific article

Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation

Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study

scientific article published on 7 August 2015

Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study

Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis

scientific article published on 29 July 2015

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

scientific article

Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study

scientific article

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study

scientific article

Thiazolidinediones and Risk of Atrial Fibrillation among Patients with Diabetes and Coronary Disease.

scientific article published on 23 March 2018

Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study

scientific article published on 8 November 2016

Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation

scientific article published in November 2017